Colorectal cancers (CRCs) displaying microsatellite instability (MSI) most often result from MLH1 deficiency. The aim of this study was to assess the impact of MLH1 expression per se on tumor evolution after curative surgical resection using a xenograft tumor model. Transplantable tumors established with the human MLH1-deficient HCT116 cell line and its MLH1-complemented isogenic clone, mlh1-3, were implanted onto the caecum of NOD/SCID mice. Curative surgical resection was performed at day 10 in half of the animals. The HCT116-derived tumors were more voluminous compared to the mlh1-3 ones (P 5 .001). Lymph node metastases and peritoneal carcinomatosis occurred significantly more often in the group of mice grafted with HCT116 (P 5 .007 and P 5 .035, respectively). Mlh1-3-grafted mice did not develop peritoneal carcinomatosis or liver metastasis. After surgical resection, lymph node metastases only arose in the group of mice implanted with HCT116 and the rate of cure was significantly lower than in the mlh1-3 group (P 5 .047). The murine orthotopic xenograft model based on isogenic human CRC cell lines allowed us to reveal the impact of MLH1 expression on tumor evolution in mice who underwent curative surgical resection and in mice whose tumor was left in situ. Our data indicate that the behavior of MLH1-deficient CRC is not only governed by mutations arising in genes harboring microsatellite repeated sequences but also from their defect in MLH1 as such.
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| I N T R O D U C T I O N
Colorectal carcinoma (CRC) is the third most common type of cancer and the second leading cause of cancer-related death. 1 Approximately onefourth of the patients can be cured by surgery alone, whereas the remaining need to be treated with chemotherapy due to metastasis at the time of diagnosis, development of metastasis, or recurrence of disease. The development of CRC involves at least three partially overlapping oncogenic pathways displaying characteristic genetic or epigenetic alterations:
microsatellite instability (MSI), CpG island methylator phenotype, and chromosome instability. [2] [3] [4] MSI CRC represent about 15% of all CRC and arise due to mismatch repair (MMR) deficiency, either as a result of inherited mutations in one of the MMR genes, most often MSH2 or MLH1, or, more often, through somatic epigenetic methylation of the MLH1 promoter. 3, 5, 6 Patients with MSI CRC have a better stage-adjusted prognosis than those with CRC displaying chromosome instability, 7, 8 and there is increasing evidence showing that MSI influences the response to chemotherapy, 3, [9] [10] [11] [12] [13] [14] [15] ionizing radiation, 16 and immunotherapy. 17, 18 It is widely accepted that MMR deficiency is not a transforming event per se, but that it promotes oncogenesis through accumulation of mutations arising during replication as they are left uncorrected due to MMR deficiency. 19, 20 Simple sequence repeats, also known as microsatellites, are particularly prone to insertion and deletion mutations resulting from polymerase slippage. Several genes involved in the control of cell proliferation and differentiation, and DNA damage signaling and repair carry a mononucleotide repeat, 21, 22 which is mutated in MSI CRC at a frequency higher than expected from their length, suggesting that their inactivation may participate in tumor initiation and/or progression. 21, 23, 24 In addition to the numerous MSI-driven mutations inactivating target genes that may be considered as putative novel oncogenes, 25 MLH1 deficiency itself may further contribute to tumor progression owing to its role in recombination 26, 27 and apoptosis. [28] [29] [30] [31] Metastasis is a multistep process that requires the ability of tumor cells to invade the underlying tissues, survive in the circulation, and colonize various organs, mostly lymph nodes, liver, and lung in the case of CRC. Most of the mutations found in CRC metastases are present in the paired primary lesion, suggesting that dissemination is an early event during cancer development. 32 Hence, the potential for metastatic development of CRC possibly relies on intrinsic properties of the primary tumor.
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Orthotopic CRC xenograft mouse models have been established by transplanting human colon cancers onto the caecum of deficient mice. [33] [34] [35] [36] Orthotopic xenografts are clinically more relevant than subcutaneous tumors as they may give rise to local or distant metastasis formation, in lymph nodes, in the peritoneum (carcinomatosis), or in the liver. 34, [36] [37] [38] [39] [40] [41] Furthermore, orthotopic xenografts are valuable models to evaluate tumor progression after curative surgical tumor resection as they represent the possible fate of tumors arising in humans, that is, cure (when there is no evidence of disease), local recurrence, or distant metastases. 39, 40 As an example, we previously reported that specific alterations of E-cadherin expression or TP53 in LoVo, an MSI colon cancer cell line, dramatically changed the rate of cure and metastatic behavior after surgical resection of the tumor. 39 The purpose of this study was to investigate whether MLH1 expression per se had an impact on the evolution of the tumor after curative surgical resection or when left in situ, using a murine orthotopic xenograft model based on the MLH1-deficient HCT116 cell line and an isogenic MLH1-complemented clone. 
| MATERIALS A ND METHODS

| Cell lines
| MSI analysis
MSI was investigated using four highly polymorphic CAn dinucleotide microsatellite markers located on three different chromosome arms (5q, 17p, and 18q). PCR was carried out in 20 lL using 0.2 mM dNTP, 0.5 U HotStarTaq polymerase (Qiagen), and sense primers labeled with 6-FAM (D5S107), HEX (D18S474) or NED (D17S1791, D18S1127).
The primer sequences are from the Ensembl Genome System website.
After a 15-min step at 958C, 35 cycles of 30 seconds at 948C, 30
seconds at 558C, and 30 seconds at 728C, followed by a 6 min final extension at 728C, were performed. PCR products were analyzed as described above for STR fingerprinting.
| Detection of frameshift mutations
The regions encompassing the repeated mononucleotide sequences contained in 26 selected genes (Table 1) were amplified either in monoplex or in multiplex PCR, as previously described. 23 Oligonucleotide sequences and protocol details are available upon request. The electrophoresis profiles of the PCR products obtained with mlh1-3
were compared to the HCT116 reference profiles. 
| MLH1 protein expression
| Animal experiments
Locally bred female NOD/SCID mice of 6-8 weeks of age were used for implantation. The animals were maintained under specific pathogen-free conditions, and food and water were supplied ad Gene symbols are according to HUGO gene nomenclature committee. Gene ID is from the NCBI Entrez gene database. The alleles detected were either wild-type (wt) or carry a 1 bp or a 2 bp deletion (noted as "21" or "22," respectively); wt: only wild-type alleles were detected; 21/wt: both wt alleles and alleles carrying a 1 bp deletion were detected; 21: only alleles with a 1 bp deletion were detected; 22/21: alleles carrying a 2 bp deletion and alleles with a 1 bp deletion were detected. All repeats are located in the coding sequences, except for MRE11A whose T11 repeat is located in an intron and whose shortening induces exon skipping; thus, a 1 or 2 bp deletion results in a frameshift mutation.
experiments (agreement no. 75-1229 approved by the "Direction D epartementale de la Protection des Populations", Paris, France). All efforts have been made to protect mice from pain, suffering, injury, and disease. 
| Tumor models
| Surgical resection
Surgical resection was performed 10 days after orthotopic transplantation. Mice were anesthetized, abdomen was prepared for sterile surgery and a median incision was made, using the above-described protocol. The colon was exposed after careful dissection and hemostasis of peritoneal adhesions. The caecum was completely resected using a surgical clip, as described. 35, 36 The clip was covered for final hemostasis and asepsis with 0.5 mL of biological glue. The bowel was replaced in the abdominal cavity and the wall was closed in two layers.
| Tumor growth and metastasis evaluation
For each animal, an autopsy was performed at day 45 after tumor implantation. Tumor volumes were calculated using the formula 
| Statistical analyses
On the basis of a unilateral alpha type one error of 5%, it was necessary to include 10 mice per group to achieve a 90% statistical power if the expected event ratio (local or distant recurrence) was 4, and 8 mice per group if the mean tumor volume ratio was expected to decrease 4-fold upon expression of MLH1. Two-sided Fisher's exact test was used to compare the proportion of mice with recurrence, lymph node metastases, peritoneal carcinomatosis, and liver metastases. Tumor volumes were compared using a one-tailed Mann-Whitney U test.
Analyses were performed using the Prism 5 software (GraphPad Software Inc, La Jolla, CA).
| R E S U L T S 3.1 | Feasibility of orthotopic intracaecal xenografts and tumor resection
Among the 60 NOD/SCID mice that had been grafted on the caecum, one died during surgery, one the following day, and one at day 8 (1/30 and 2/30 for HCT116 and mlh1-3, respectively), giving a 5% graftrelated mortality. Among the 27 animals that did not undergo surgery, tumor graft implantation was successful in 21 animals (10/14 and 11/13 for HCT116 and mlh1-3, respectively), giving an overall tumor take rate of 78%. Among the 30 animals that underwent surgical resection at day 10, five of them (16%) died during the first 8 days after surgical tumor resection (2/15 and 3/15 for HCT116-R and mlh1-3-R, respectively), with one dying the next day.
Microscopy of hematoxylin-eosin (HE) sections showed that macroscopic tumors from both HCT116 and mlh1-3 exhibited invasive growth in the murine caecum toward the intestinal lumen ( Figure 1A,B) ; both HCT116 and mlh1-3 tumors were able to grow through the serosa and invade the muscular layer and the mucosa. Visual examination at autopsy and microscopic examination of HE-stained sections showed that tumors also gave rise to lymph node metastases ( Figure 1C,D) , liver metastases in one case ( Figure 1E,F) , and peritoneal carcinomatosis (Figure 1G,H) . HCT116-derived tumors cells were more frequently poorly differentiated, with increased necrosis, than mlh1-3; in addition, HCT116 cells were smaller and less cohesive. We further compared the mutational status of 26 genes harboring a mononucleotide repeat in HCT116 and mlh1-3 cells ( were identical for all samples tested confirming that mlh1-3 and intracaecal tumors derived from HCT116. Yet, there were minor differences between the HCT116 and mlh1-3 profiles and the one available at the ATCC website. The first difference was located at the vWA marker and consisted of an addition of a single nucleotide that was detected in generating a size that is identical to that of the X-chromosome.
| Molecular characteristics of the HCT116 and mlh1-3 cell lines and their counterpart tumors
| Spontaneous evolution of the HCT116 and mlh1-3 intracaecal tumor xenografts
As shown in Table 2 and Figure 3 , the mean tumor volume in the group of mice implanted with mlh1-3-derived tumors was significantly smaller than in those with HCT116 (P 5 .001), despite large variations within each group. Lymph node metastases and peritoneal carcinomatosis occurred significantly more often in the group of mice grafted with HCT116, compared to the group of mlh1-3 tumor-bearing animals (P 5 .007 and P 5 .035, respectively) ( Table 2 ). Mice grafted with mlh1-3 tumors did not develop peritoneal carcinomatosis or liver metastasis; the only liver metastasis was observed in the group of mice grafted with the HCT116 tumor ( Table 2 ).
| Evolution of the HCT116 and mlh1-3 intracaecal tumor xenografts after surgical resection
To study tumor evolution after curative surgery, HCT116 and mlh1-3 intracaecal tumor xenografts were resected at day 10. The rate of local recurrence after surgical resection did not differ significantly between the two groups, varying from 38% (5/13) for HCT116-R to 25% (3/12) for mlh1-3-R (Table 2) ; tumor volumes varied widely in both groups and were not significantly different. Lymph node metastases occurred only in the group of mice initially implanted with the HCT116 tumor, but the difference failed to reach the level of significance (P 5 .096).
Moreover, a single mouse of the mlh1-3 group displayed peritoneal carcinomatosis, whereas it occurred at a significantly higher frequency in mice initially grafted with the HCT116 tumor (P 5 .011). No liver metastases were detected in either group. The rate of cure was significantly higher in the mlh1-3 group in which only 3/12 animals relapsed, while 9/13 animals of the HCT116 group relapsed (P 5 .047) ( Table 2 ). Fifteen mice were initially grafted in each group; the number of mice analyzed decreased due to early death after tumor graft (n 5 3) or surgical resection (n 5 5), and to the absence of tumor take (n 5 6). The volumes of tumors growing on the caecum were compared using a one-tailed Mann-Whitney U test. To compare the number of mice with recurrence, lymph node metastases, peritoneal carcinomatosis, and liver metastases, P values were calculated using two-sided Fisher's exact tests. a not analyzed (na): no P value could be calculated to compare the number of mice with liver metastases after tumor resection as there was no event in either group.
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whether the tumor was resected or not. This is in line with a recent publication reporting that as many as 25% of the tumors arising in patients undergoing cytoreductive surgery for peritoneal carcinomatosis from CRC displayed MSI, a frequency that is higher than in unselected stage IV CRC, suggesting that MSI might favor peritoneal metastases. 57 The decreased incidence of lymph node invasion was statistically significant when comparing mice that did not undergo surgery, but not for mice that underwent tumor resection, possibly due to lack of power as the number of mice was rather low. Yet, ethical considerations led us to reduce the number of animals used to achieve our aim, which was to document substantial differences in tumor progression.
MSI CRC are considered to have a better prognosis compared to MSS CRC, but the underlying molecular alterations have not been identified yet. 58 In In our xenograft experiments, the absence of MLH1 expression tended to be associated with a worse evolution, while patients with MSI CRC had a better stage-adjusted prognosis than those with CRC displaying chromosome instability. 7, 8 The major distinction between these apparently contradictory findings is that, in humans, the differences between MSI and non-MSI tumors reside not only in the fact that one of the MMR genes (most often MLH1 or MSH2) is not functional, but also in the genome-wide accumulation of de novo mutations due to inefficient postreplicative repair, while in the animal model that we used, the only difference that we could detect was MLH1 expression.
Although such animal models may help deciphering the impact of specific genetic alterations, such as MLH1 deficiency, on cancer progression, there are several limitations. Tumor xenograft models are not well suited to study interactions between cancer cells and tumor environment because interspecies molecular communications, including ligand-receptor interactions, are likely to differ. 54 In addition, being severely immunocompromised, NOD/SCID mice obviate assessing the well-recognized role of the immune system, in the metastatic process in CRC. 63 Addressing this question would be extremely hard as reconstitution of a human immune system in immunodeficient mice should be done with patient-matched immune cells, which greatly limits the feasibility.
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